“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...

Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...

New data for Arexvy, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease: London, UK Friday, October 25, 2024, 13:00 Hr ...

GSK (GSK) reported its RSV vaccine Arexvy elicited a robust immune response in people aged 18 to 49 years who were at ...

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...

Undervalued by 30%, the shares of this wide-moat company look appealing today.

LSL PHARMA GROUP INC. ("LSL Pharma" or the "Corporation"), an integrated Canadian-based pharmaceutical company, reports that it will make on October 31, 2024, the first interest payment (the "Interest ...

DefenAge Skincare is excited to announce the launch of its newest innovation, the 12-Factor Revitalizing Lip Enhancer. Powered by DefenAge's patented Age-Repair Defensins®, this groundbreaking lip ...

Secretary of State Antony J. Blinken said U.S. and Qatari negotiators would soon restart long-stalled negotiations, but that it remained unclear if Hamas was willing to engage. Sirajuddin Haqqani ...

Democratic presidential candidate Kamala Harris heads to the battleground of Georgia on Thursday for a star-studded rally featuring rock legend Bruce Springsteen, entertainer Tyler Perry and ...